Paper39656241
Impact of administration routes and dose frequency on the toxicology of SARS-CoV-2 mRNA vaccines in mice model.
Ahn JH and 14 others. Arch Toxicol, 2025. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Impact of administration routes and dose frequency on the toxicology of SARS-CoV-2 mRNA vaccines in mice model. Papers, record 39656241. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39656241
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of administration routes and dose frequency on the toxicology of SARS-CoV-2 mRNA vaccines in mice model.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 Vaccines | Major topic |
| COVID-19 | Major topic |
| SARS-CoV-2 | Major topic |
| Animals | |
| Mice, Inbred ICR | |
| Mice | |
| Injections, Intramuscular | |
| Spike Glycoprotein, Coronavirus | |
| Nanoparticles | |
| Male | |
| Female | |
| Dose-Response Relationship, Drug | |
| Vaccines, Synthetic | |
| Antibodies, Viral | |
| mRNA Vaccines | |
| Immunoglobulin G | |
| Liposomes |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 22213MFDS421 | Ministry of Food and Drug Safety | PubMed |
Source PubMed
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9427047 | Involution of the mammalian thymus, one of the leading regulators of aging. | In Vivo | 1997 | https://conductscience.org/library/papers/9427047 | PubMed |
| 2 | 34738500 | Evaluating the relationship between myocarditis and mRNA vaccination. | Expert Rev Vaccines | 2022 | https://conductscience.org/library/papers/34738500 | PubMed |
| 3 | 26933083 | Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction. | Circulation | 2016 | https://conductscience.org/library/papers/26933083 | PubMed |
| 4 | 34181446 | Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine. | Ann Intern Med | 2021 | https://conductscience.org/library/papers/34181446 | PubMed |
| 5 | 23451884 | Solid lipid nanoparticles induced hematological changes and inflammatory response in mice. | Nanotoxicology | 2014 | https://conductscience.org/library/papers/23451884 | PubMed |
| 6 | 11792348 | Effect of myocardial ischemia on cardiac troponin I and T. | Am J Cardiol | 2002 | https://conductscience.org/library/papers/11792348 | PubMed |
| 7 | 11165984 | Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise. | Am J Cardiol | 2001 | https://conductscience.org/library/papers/11165984 | PubMed |
| 8 | 10451243 | Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis? | Clin Chim Acta | 1999 | https://conductscience.org/library/papers/10451243 | PubMed |
| 9 | 24755410 | Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. | Blood | 2014 | https://conductscience.org/library/papers/24755410 | PubMed |
| 10 | 34185046 | Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. | JAMA Cardiol | 2021 | https://conductscience.org/library/papers/34185046 | PubMed |
| 11 | 35814615 | Optimization of Lipid Nanoformulations for Effective mRNA Delivery. | Int J Nanomedicine | 2022 | https://conductscience.org/library/papers/35814615 | PubMed |
| 12 | 23071157 | Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis. | Circ Res | 2013 | https://conductscience.org/library/papers/23071157 | PubMed |
| 13 | 38368913 | Lipid nanoparticles containing labile PEG-lipids transfect primary human skin cells more efficiently in the presence of apoE. | Eur J Pharm Biopharm | 2024 | https://conductscience.org/library/papers/38368913 | PubMed |
| 14 | 33900279 | Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT). | Med Sci Monit | 2021 | https://conductscience.org/library/papers/33900279 | PubMed |
| 15 | 25449546 | Efficient backsplicing produces translatable circular mRNAs. | RNA | 2015 | https://conductscience.org/library/papers/25449546 | PubMed |
| 16 | 19591929 | Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. | Eur J Pharm Sci | 2009 | https://conductscience.org/library/papers/19591929 | PubMed |
| 17 | 8319322 | Cardiac troponin I. A marker with high specificity for cardiac injury. | Circulation | 1993 | https://conductscience.org/library/papers/8319322 | PubMed |
| 18 | 37779140 | Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37779140 | PubMed |
| 19 | 16259561 | Gene therapy for lipoprotein lipase deficiency: working toward clinical application. | Hum Gene Ther | 2005 | https://conductscience.org/library/papers/16259561 | PubMed |
| 20 | 21752618 | Altered thymic activity in early life: how does it affect the immune system in young adults? | Curr Opin Immunol | 2011 | https://conductscience.org/library/papers/21752618 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42935198 | [Safety and humoral immune responses of an inactivated whole-cell lysate of Mycobacterium tuberculosis B/R fusion strain prepared by combined ultrasonic disruption and enzymatic digestion]. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2026 | https://conductscience.org/library/papers/42935198 | PubMed |
| 42773168 | Microfluidics-mediated spatial control of mRNA lipid nanoparticles primes translation and enhances vaccine potency. | Nat Biomed Eng | 2026 | https://conductscience.org/library/papers/42773168 | PubMed |
| 42711375 | Charge-switching ionizable lipids lower the toxicity of lipid nanoparticles. | Nat Nanotechnol | 2026 | https://conductscience.org/library/papers/42711375 | PubMed |
| 42514871 | Analytical Characterization and Stability Assessment of RNA-Based Vaccines. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514871 | PubMed |
| 42446848 | Nanomaterial toxicity and risk assessment integrating functionalization strategies advanced in vitro models and regulatory perspectives. | Discov Nano | 2026 | https://conductscience.org/library/papers/42446848 | PubMed |
| 42282251 | Comparative analysis of expression, immunogenicity, and safety profiles between linear and circular RNA vaccine platforms. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42282251 | PubMed |
| 42117531 | Lipid Nanoparticle Surface Engineering with Heparosan Polysaccharides for Safe and Effective mRNA Delivery In Vitro and In Vivo. | ACS Appl Mater Interfaces | 2026 | https://conductscience.org/library/papers/42117531 | PubMed |
| 41835055 | Delivery Systems of mRNA Vaccines in the Treatment of Infectious Diseases: From Lipid Nanoparticles to Next-Generation Platforms. | Adv Pharm Bull | 2025 | https://conductscience.org/library/papers/41835055 | PubMed |
| 41393308 | Rational design and applications of piperazine and cyclohexane ionizable lipids for PKU and SSADH deficiency. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/41393308 | PubMed |
| 41361115 | SARS-CoV-2 mRNA vaccines: unresolved mechanisms of myocardial damage. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/41361115 | PubMed |
| 41189930 | PEGylated lipids in lipid nanoparticle delivery dynamics and therapeutic innovation. | Beilstein J Nanotechnol | 2025 | https://conductscience.org/library/papers/41189930 | PubMed |
| 40410742 | Evaluation of broad-spectrum protection by novel mRNA vaccines against SARS-CoV-2 variants (Delta, Omicron-BA.5, XBB-EG.5) in the golden hamster model. | Virol J | 2025 | https://conductscience.org/library/papers/40410742 | PubMed |
| 40303917 | Acute and subacute toxicity evaluation of ZhenzhuXiaoji decoction in preclinical models: implications for safe clinical use. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40303917 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39656241
GET https://conductscience.org/api/papers/v1/39656241/references?page=2